Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002942754 | SCV003271933 | uncertain significance | Cowden syndrome | 2022-09-23 | criteria provided, single submitter | clinical testing | This variant has not been reported in the literature in individuals affected with PIK3CA-related conditions. This sequence change replaces asparagine, which is neutral and polar, with serine, which is neutral and polar, at codon 284 of the PIK3CA protein (p.Asn284Ser). This variant is not present in population databases (gnomAD no frequency). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Ambry Genetics | RCV004958864 | SCV005468858 | uncertain significance | Inborn genetic diseases | 2024-11-05 | criteria provided, single submitter | clinical testing | The p.N284S variant (also known as c.851A>G), located in coding exon 4 of the PIK3CA gene, results from an A to G substitution at nucleotide position 851. The asparagine at codon 284 is replaced by serine, an amino acid with highly similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Based on the available evidence, the clinical significance of this variant remains unclear. |